Nk cells and T cells cooperate during the clinical course of colorectal cancer

OncoImmunology

Volumn 3, Issue 8, 2014, Pages 1-6

  Sconocchia, Giuseppe ^a   Eppenberger, Serenella ^b   Spagnoli, Giulio C ^b   Tornillo, Luigi ^b   Droeser, Raoul ^b   Caratelli, Sara ^a   Ferrelli, Francesca ^c   Coppola, Andrea ^c   Arriga, Roberto ^c   Lauro, Davide ^c   Iezzi, Giandomenica ^b   Terracciano, Luigi ^b   Ferrone, Soldano ^d  

^a INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CD8 T cell; Colorectal carcinoma; Cooperation; Lymphocyte; NK cell; Survival; Tumor

Indexed keywords

CD56 ANTIGEN;

ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; COLORECTAL CANCER; CYTOFLUOROMETRY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE MICROARRAY; TUMOR MICROENVIRONMENT;

EID: 84946033871     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/21624011.2014.952197     Document Type: Article

References (33)

1. McLean MH, Murray GI, Stewart KN, Norrie G, Mayer C, Hold GL, Thomson J, Fyfe N, Hope M, Mowat NAG, et al. The inflammatory microenviron-ment in colorectal neoplasia. PLoS One 2011; 6: e15366; PMID:21249124; http://dx.doi.org/10.1371/journal.pone.0015366
2. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R, Jalkanen S. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Can-cer2012; 131:864-73; PMID:21952788; http://dx.doi.org/10.1002/ijc.26457
3. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin.Cancer Res 2007; 13:1472-9; PMID:17332291
4. Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, et al. Tumor infiltration by FcgammaRIII (CD16) Cmyeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011; 128:2663-72; PMID:20715106; http://dx.doi.org/10.1002/ijc.25609
5. Droeser RA, Hirt C, Eppenberger-Castori S, Zlobec I, Viehl CT, Frey DM, Nebiker CA, Rosso R, Zuber M, Amicarella F, et al. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One 2013; 8: e64814; PMID:23734221; http://dx.doi.org/10.1371/journal.pone.0064814
6. Hirt C, Eppenberger-Castori S, Sconocchia G, Iezzi G, Tornillo L, Terracciano L, Spagnoli GC, Droeser R. Colorectal cancer infiltration by myeloperoxidase positive neutrophil granulocytes is associated with favorable prognosis. Oncoimmunology 2013; 2: e25990; PMID:24244897; http://dx.doi.org/10.4161/onci.25990
7. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nils-son M, Damotte D, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 2005; 353:2654-66; http://dx.doi.org/10.1056/NEJMoa051424
8. Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L. High frequency of tumor-infiltrating FOXP3(C) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 2010; 126:2635-43; PMID:19856313
9. Desbois M, Rusakiewicz S, Locher C, Zitvogel L, Chaput N. Natural killer cells in non-hematopoietic-malignancies. Front Immunol 2012; 3:395; PMID:23269924; http://dx.doi.org/10.3389/fimmu.2012.00395
10. Savani BN, Rezvani K, Mielke S, Montero A, Kur-lander R, Carter CS, Leitman S, Read EJ, Childs R, Barrett AJ. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006; 107:1688-95; PMID:16131570; http://dx.doi.org/10.1182/blood-2005-05-1897
11. Savani BN, Mielke S, Adams S, Uribe M, Rezvani K, Yong AS, Zeilah J, Kurlander R, Srinivasan R, Childs R, et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leuke-mias but not with acute lymphoblastic leukemia. Leukemia 2007; 21:2145-52; PMID:17673900; http://dx.doi.org/10.1038/sj.leu.2404892
12. Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I. Decrease in intrahepatic CD56 Clymphocytes in gastric and colorectal cancer patients with liver metastases. APMIS 2009; 117:870-9; PMID:20078551; http://dx.doi.org/10.1111/j1600-0463.2009.02547x
13. Marechal R, De SJ, Nagy N, Demetter P, Lemmers A, Deviere J, Salmon I, Tejpar S, Van Laethem JL. Putative contribution ofCD56 positive cells in cetux-imab treatment efficacy in first-line metastatic colo-rectal cancer patients. BMC Cancer 2010; 10:340; PMID:20591136; http://dx.doi.org/10.1186/1471-2407-10-340
14. Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 2004; 84:493-501; PMID:14968119
15. Sandel MH, Speetjens FM, Menon AG, Albertsson PA, Basse PH, Hokland M, Nagelkerke JF, Tollenaar RA, van de Velde CJ, Kuppen PJ. Natural killer cells infiltrating colorectal cancer and MHC class I expression. MolImmunol. 2005; 42:541-6.
16. Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N, Koch M, Weitz J, Kloor M, Zoernig I, et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res 2011; 17:678-89.
17. Sconocchia G, Spagnoli GC, Del Principe D, Fer-rone S, Anselmi M, Wongsena W, Cervelli V, Schultz-Thater E, Wyler S, Carafa V, et al. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-medi-ated interaction. Neoplasia 2009; 11:662-71; PMID:19568411
18. Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions-letter. Cancer Res 2012; 72:5428-9; PMID:23047870; http://dx.doi.org/10.1158/0008-5472.CAN-12-1181
19. Shanker A, Verdeil G, Buferne M, Inderberg-Suso EM, Puthier D, Joly F, Nguyen C, Leserman L, Auphan-Anezin N, Schmitt-Verhulst AM. CD8 T cell help for innate antitumor immunity. J Immunol 2007; 179:6651-62; http://dx.doi.org/10.4049/jimmunol.179.10.6651
20. Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson C, Lopez-Albaitero A, Gibson SP, Gooding WE, Ferrone S, et al. Cetuximab-activated natural killer (NK) and dendritic cells (DC) collaborate to trigger tumor antigen-specific T cell immunity in head and neck cancer patients. Clin. Cancer Res 2013; 19:1858-72; PMID:23444227; http://dx.doi.org/10.1158/1078-0432.CCR-12-2426
21. Grzywacz B, Kataria N, Verneris MR. CD56(dim) CD16(C) NK cells downregulate CD16 following target cell induced activation ofmatrix metalloproteinases. Leukemia 2007; 21:356-9; PMID:17251901; http://dx.doi.org/10.1038/sjleu.2404499
22. Harrison D, Phillips JH, Lanier LL. Involvement ofa metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gammaRIII (CD16-II). J. Immunol. 1991; 147:345965; PMID:8558016
23. Jewett A, Bonavida B. Target-induced inactivation and cell death by apoptosis in a subset ofhuman NK cells. J. Immunol. 1996; 156:907-15; PMID:8558016
24. Ortaldo JR, Mason AT, O'SheaJJ. Receptor-induced death in human natural killer cells: involvement of CD16. J Exp Med 1995; 181:339-44; PMID:7528771; http://dx.doi.org/10.1084/jem.181.1.339
25. Pietra G, Vitale M, Manzini C, Balsamo M, Moretta L, Mingari MC. Melanoma cells inhibit NK cell functions-response. Cancer Res 2012; 72:5430; http://dx.doi.org/10.1158/0008-5472.CAN-12-2526
26. Pietra G, Manzini C, Rivara S, Vitale M, Cantoni, Petretto A, Balsamo M, Conte R, Benelli R, Min-ghelli S, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.org/10.1158/0008-5472.CAN-11-2544
27. Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR. Tumor-induced apoptosis of human IL-2-acti-vated NK cells: role of natural cytotoxicity receptors. J Immunol 2005; 174:2653-60; PMID:15728472; http://dx.doi.org/10.4049/jimmunol.1745.2653
28. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
29. Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F. Grube M, Melenhorst J, Barrett AJ. G-CSF-mobilized CD34C cells cultured in interleu-kin-2 and stem cell factor generate a phenotipically novel monocyte. J Leuk Biol 2004; 76:1214-9; http://dx.doi.org/10.1189/jlb.0504278
30. Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G, Sestigiani C, Mariotti C, Birtolo S, Tozzi M, et al. CD56antigenicexpressioninacute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 2001; 15:1161-4; PMID:11480556; http://dx.doi.org/10.1038/sjleu.2402174
31. Zecchini S, Bombardelli L, Decio A, Bianchi M, Mazzarol G, Sanguinetti F, Aletti G, Maddaluno L, Berenzin V, Bock E, et al. The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signaling. EMBO Mol Med 2011; 3:480-94; PMID:21739604; http://dx.doi.org/10.1002/emmm.201100152
32. Cavallaro U, Niedermeyer J, Fuxa M, Christofori G. N-CAM modulates tumor-cell adhesion to matrix by inducing FGF-receptor signaling. Nat Cell Biol 2001; 3:650-57; PMID:11433297; http://dx.doi.org/10.1038/35083041
33. Cirovic S, Vjestica J, Mueller CA, Tatic S, Vasiljevic J, Milenkovic S, Mueller GA, Markovic-Lipkovski J. NCAM and FGFR1 coexpression and colocalization in renal tumors. Int J Clin Exp Pathol 2014; 7:140214; PMID:24817936